Post-effective amendment to a registration statement that is not immediately effective upon filing

Subsequent Events (Detail Textuals)

v3.19.3.a.u2
Subsequent Events (Detail Textuals) - USD ($)
 1 Months Ended 12 Months Ended
Dec. 20, 2019
Dec. 19, 2019
Feb. 28, 2019
Feb. 01, 2019
Jan. 31, 2019
Dec. 31, 2017
Subsequent Event [Line Items]            
Value of warrants issued           $ 145,200
Subsequent Event | Pharmaceuticals International, Inc. Agreement            
Subsequent Event [Line Items]            
Estimated initial payment for contract         $ 72,500  
Subsequent Event | RRD International Agreement            
Subsequent Event [Line Items]            
Amount of payments due under the contract         78,680  
Amount of pass through expenses and consulting fees         $ 22,000  
Subsequent Event | 2nd Draw on Multi Draw Credit Facility            
Subsequent Event [Line Items]            
Value of warrants issued       $ 2,000,000    
Number of warrants issued       2,500,000    
Warrant exercise price       $ 0.50    
Subsequent Event | Noramco Agreement            
Subsequent Event [Line Items]            
Upfront payment     $ 146,386      
Subsequent Event | Independent Contractor Services Agreement | Dr. Avtar Dhillon            
Subsequent Event [Line Items]            
Monthly fee   $ 10,000        
Monthly fee paid each month   5,000        
Monthly fee accruing from effective date   $ 5,000        
Subsequent Event | Warrant Exercise Agreement | Emerald Health Sciences Inc            
Subsequent Event [Line Items]            
Number of warrants exercised 40,800,000          
Aggregate exercise price of warrants $ 4,080,000          
Remaining balance of credit facility $ 2,014,500